The agency approved of the single-strain mRNA COVID-19 vaccines for people aged 12 and older and granted emergency use authorization for those aged 6 months to 11 years.
FDA green-lights season’s updated mRNA COVID vaccines
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows